课题基金 / 基金详情

Scaling the ChIP-chip assay to improve analysis of clinical biospecimens

Scaling the ChIP-chip assay to improve analysis of clinical biospecimens
扩展 ChIP 芯片检测以改进临床生物样本的分析
批准号:
7442311
负责人:
PEGGY J Farnham
金额:
$19.0万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2010-06-30

项目摘要

项目成果

PEGGY J Farnham的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):识别正常细胞转化为肿瘤细胞时发生的基因表达变化可以揭示可用于诊断的分子标记,并提出潜在的新治疗靶点。然而,通过表征肿瘤特异性基因表达模式的机制,人们也可以深入了解驱动肿瘤形成的分子过程。我们开发了一种基于ChIP-chip技术的方案(称为MAGIC分析),可用于研究基因表达的改变,并确定基因表达的改变是否由于转录复合物形成的变化、表观遗传介导的基因沉默或基因拷贝数的改变。该方法使用针对RNAPII的抗体、针对修饰组蛋白H3的抗体和针对甲基化DNA的抗体来鉴定基因组的活性区和沉默区。它还采用正常和肿瘤样本的基因组比较来识别基因组的扩增和删除区域。大多数进行ChIP-chip分析的研究人员使用培养的细胞。显然,如果对通过显微解剖、激光捕获或其他分离方法获得的肿瘤细胞纯群体进行分析,该技术将对表征癌症基因组更有用。将ChIP- ChIP技术用于此类样品的研究需要修改样品制备,调整ChIP分析以适应少量细胞,并改进ChIP样品的扩增,以便在使用少量输入DNA时能够保持实验和对照样品的准确表示。我们建议修改ChIP方案以用于少量细胞(Aim I),以确定从少量细胞(Aim II)中获得的ChIP样品的最佳扩增方法,并证明修改后的方案适用于通过激光捕获显微镜从肿瘤样品中获得的细胞分析(Aim III)。我们建议对ChIP-chip技术进行改进,使其能够在激光捕获显微镜采集少量肿瘤细胞后使用。这样的修饰将是癌症基因组分子特征的一大进步。
英文摘要
DESCRIPTION (provided by applicant): Identifying gene expression changes that occur when a normal cell transforms into a neoplastic cell can reveal molecular markers that can be used for diagnosis and suggest potential new therapeutic targets. However, by characterizing the mechanisms by which the tumor-specific gene expression patterns have been created, one can also gain insight into the molecular processes that drive tumor formation. We have developed a protocol (termed a MAGIC analysis), based on the technique of ChIP-chip, that can be used both to study altered gene expression and to determine if the altered gene expression is due to changes in transcription complex formation, epigenetic-mediated gene silencing, or alterations in gene copy number. This method uses an antibody to RNAPII, an antibody to modified Histone H3, and an antibody to methylated DNA to identify active vs. silent regions of the genome. It also employs a genomic comparison of the normal and tumor samples to identify amplified and deleted regions of the genome. Most investigators who perform ChIP-chip assays use cultured cells. Clearly, this technique would be much more useful for characterizing the cancer genome if pure populations of tumor cells, obtained by microdisssection, laser capture, or other separation methods were analyzed. Adapting the ChIP-chip technique for the study of such samples requires modifications to sample preparation, scaling the ChIP assay to accommodate a small number of cells, and improving the amplification of the ChIP sample such that accurate representation of the experimental and control samples can be maintained when using small amounts of input DNA. We propose to modify the ChIP protocol for use with very small numbers of cells (Aim I), to determine the optimal amplification method for ChIP samples obtained from a small number of cells (Aim II), and to demonstrate that the modified protocols are suitable for analysis of cells obtained from tumor samples by laser capture microscopy (Aim III). We propose to modify the technique of ChIP-chip such that it can be used after collection of a small number of tumor cells by laser capture microscopy. Such modifications would be a great advance in the molecular characterization of the cancer genome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of a novel family of human transcription factors that bind at +240 downstream of the transcription start site.
Characterization of a novel family of human transcription factors that bind at +240 downstream of the transcription start site.
Core-009
Core-009
海外基金